2-amino-4-phenylbutyric acid has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulat, S; Cerezo-Gálvez, S; Edwards, PJ; Feurer, A; Hill, O; Hoffmann-Enger, B; López-Canet, M; Matassa, VG; Nordhoff, S; Rosenbaum, C; Rummey, C; Thiemann, M | 1 |
1 other study(ies) available for 2-amino-4-phenylbutyric acid and Diabetes Mellitus, Type 2
Article | Year |
---|---|
The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacements.
Topics: Amides; Aminobutyrates; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Design; Humans; Hypoglycemic Agents; Protease Inhibitors; Sodium Channels; Structure-Activity Relationship | 2009 |